# 一名嚴重過敏性氣喘個案在診所接受omalizumab皮下注射。哪一項給藥後措施最符合FDA黑框警告？

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=391797&lang=zh-tw  
> language: zh-TW  
> subject: Adverse Effects/Contraindications/Interactions  
> category: PPT

## 題目

一名嚴重過敏性氣喘個案在診所接受omalizumab皮下注射。哪一項給藥後措施最符合FDA黑框警告？

## 選項

1. 立即讓病人離開以縮短診所停留時間
2. 為節省資源在診所外給藥
3. 先給diphenhydramine再讓病人回家
4. 前幾次給藥後在診所觀察至少2小時，之後至少30分鐘，且立即可用過敏性休克急救用品；並衛教可能延遲至24小時的反應 **✔ 正確答案**

**正確答案: 4**

## 解析

正確 (2)：Omalizumab有FDA過敏性休克黑框警告，可能危及生命，可發生於第一次或任何後續劑量，有時延遲至24小時才發生。需在醫療場所觀察（初期2小時，穩定後續劑量30分鐘），並備妥過敏性休克急救用品。也會提供病人腎上腺素自動注射器。(1,3) 不安全。(4) 預先用藥不能消除過敏性休克風險。

## 深入解析

記憶提示 Omalizumab（抗IgE）=「抗IgE要記得過敏性休克警告」。所有氣喘生物製劑（omalizumab、mepolizumab、benralizumab、dupilumab）都有過敏反應警告。

## 臨床情境

情境 28歲女性，嚴重過敏性氣喘，每4週接受omalizumab 300 mg SC。於診所給藥。

## 重要概念

- **奧馬珠單抗** — 用於嚴重過敏性氣喘與慢性蕁麻疹的抗IgE單株抗體。
- **過敏性休克監測** — 因生物製劑有過敏性休克風險，需給藥後觀察並立即備妥epinephrine。
- **氣喘生物製劑** — 重度氣喘追加治療，如omalizumab、mepolizumab、benralizumab、reslizumab、dupilumab。

## 相同主題題目

- [A nurse is reviewing the morning lab results for an adult client receiving warfarin for at…](https://mymerci.kr/pages/nclex_q.php?qn_id=360515&lang=zh-tw)
- [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=zh-tw)
- [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=zh-tw)
- [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=zh-tw)
- [A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next do…](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=zh-tw)
- [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=zh-tw)
- [An 80-year-old male with heart failure is prescribed digoxin 0.125 mg daily. During mornin…](https://mymerci.kr/pages/nclex_q.php?qn_id=372686&lang=zh-tw)
- [A 38-year-old female with rheumatoid arthritis is being discharged with a new prescription…](https://mymerci.kr/pages/nclex_q.php?qn_id=372687&lang=zh-tw)

## 以其他語言閱讀

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=391797&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=391797&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=391797&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=391797&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=391797&lang=vi)

---

More free questions: [NCLEX-RN 題庫](https://mymerci.kr/pages/nclex_bank.php?lang=zh-tw)

_僅供學習參考。實際臨床請遵循最新指引與所屬機構規範。_